New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill AR190

Introduced
5/18/23  

Caption

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

Impact

AR190 emphasizes the necessity of resolving conflicting decisions from federal courts that have emerged regarding mifepristone. The drug, which has been deemed safe and effective for terminating pregnancies up to ten weeks and for the treatment of miscarriages, is crucial for reproductive health. The resolution explicitly urges the Supreme Court to respect medical providers' roles and consider public health and individual rights when making determinations that affect access to such essential medications. If mifepristone is restricted or banned, millions of women could lose access to this vital form of health care.

Summary

Assembly Resolution No. 190 (AR190) urges the United States Supreme Court to protect the freedom of reproductive choice regarding the use and access to mifepristone. The resolution highlights the current crisis in reproductive health care due to various judicial rulings that have created significant uncertainty for women seeking reproductive health services. It specifically addresses the implications of the Supreme Court's 2022 ruling in Dobbs v. Jackson Women's Health Organization, which overturned Roe v. Wade and led to varying interpretations of reproductive rights at the state level, posing risks to women's access to necessary medical care.

Contention

The resolution underscores a considerable divide in opinions surrounding reproductive rights, with concerns that continued judicial challenges undermine established medical practices and the ability of individuals to make informed health care decisions. The narrative articulated in AR190 is that legislative and judicial actions are cooperating to restrict women's rights, which has profound implications for public health. Critics argue that the resolution's call for protection may face opposition from those who hold contrary views on reproductive rights and the role of government in personal health matters.

Companion Bills

No companion bills found.

Previously Filed As

NJ SR78

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

NJ SB1428

Reproductive health: mifepristone and other medication.

NJ AR148

Condemns action of Republican members of United States Congress in failing to support passage of SB3612; affirms New Jersey Legislature's commitment to protecting reproductive freedom and full access to reproductive health care.

NJ AR122

Condemns Alabama Supreme Court ruling in LePage v. Mobile Infirmary Clinic, P.C. and pending federal legislation, H.R.431; reaffirms freedom of access and protection of reproductive health care services in New Jersey, including IVF.

NJ SR510

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

NJ AR127

Condemns Arizona Supreme Court ruling in Planned Parenthood v. Mayes banning abortions in the state and reaffirms New Jersey citizens' freedom to access reproductive health care services.

NJ SR96

Condemns Arizona Supreme Court ruling in Planned Parenthood v. Mayes banning abortions in the state and reaffirms New Jersey citizens' freedom to access reproductive health care services.

NJ A1183

"Reproductive Freedom Act."

NJ SB188

Protections For Accessing Reproductive Health Care

NJ AJR207

Urges Congress to call constitutional convention to consider reproductive health care rights.

Similar Bills

NJ SR78

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

US HR309

Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.

CA SB1428

Reproductive health: mifepristone and other medication.

MI HR0072

A resolution to condemn the April 7, 2023, order in the case Alliance for Hippocratic Medicine v. FDA and to denounce any and all efforts to limit access to abortion in Michigan and throughout the country.

CA AB54

Access to Safe Abortion Care Act.

HI SR42

Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.

HI SCR47

Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.

HI SCR14

Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.